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Abstract
Background: Accumulating evidence links paternal adiposity in the periconceptional pe-
riod to offspring health outcomes. DNA methylation has been proposed as a mediating
mechanism, but very few studies have explored this possibility in humans.
Methods: In the Pregnancy And Childhood Epigenetics (PACE) consortium, we con-
ducted a meta-analysis of coordinated epigenome-wide association studies (EWAS) of
paternal prenatal body mass index (BMI) (with and without adjustment for maternal BMI)
in relation to DNA methylation in offspring blood at birth (13 data sets; total n¼ 4894)
and in childhood (6 data sets; total n¼1982).
Results: We found little evidence of an association at either time point: at all CpGs, the
false-discovery-rate-adjusted P-values were >0.05. In secondary sex-stratified analyses,
we found just four CpGs for which there was robust evidence of an association in female
offspring. To compare our findings to those of other studies, we conducted a systematic
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review, which identified seven studies, including five candidate gene studies showing
associations between paternal BMI/obesity and offspring or sperm DNA methylation at
imprinted regions. However, in our own study, we found very little evidence of enrich-
ment for imprinted genes.
Conclusion: Our findings do not support the hypothesis that paternal BMI around the
time of pregnancy is associated with offspring-blood DNA methylation, even at imprinted
regions.
Key words: Paternal, fathers, body mass index, DNA methylation, epigenetics, DOHaD, pregnancy
Introduction
Accumulating evidence links paternal exposures in the
periconceptional period to offspring health outcomes.1–3
Results from animal studies support a causal role for ‘pa-
ternal effects’4 that are independent of maternal effects.2
Whereas prenatal maternal effects are most commonly
postulated to occur via fetal intrauterine exposure, the sug-
gested biological mechanisms underlying paternal effects3,5
include germline de novo genetic mutations6 or epigenetic
changes,7 or alterations in the components or properties of
semen.8
Epigenetic mechanisms that have been studied in rela-
tion to paternal exposures include DNA methylation, his-
tone modification and microRNA expression,7 all of which
can induce mitotically heritable alterations in gene expres-
sion without changes to the DNA sequence. At most loci,
patterns of DNA methylation are erased shortly after fertil-
ization to create totipotent cells. However, some loci (most
notably imprinted regions) can evade erasure, thus raising
the possibility of intergenerational paternal epigenetic
inheritance.9,10
A large proportion of the research on paternal effects
has explored dietary and metabolic exposures in relation
to offspring metabolism and adiposity, sometimes includ-
ing exploration of the potential mediating role of DNA
methylation in sperm and offspring. Animal models of
high-fat-diet-induced paternal obesity and diabetes have
found associations with impaired offspring development11
and offspring metabolic phenotypes and DNA methylation
in pancreatic islets.12 In humans, a recent systematic re-
view13 found conflicting evidence on the association be-
tween paternal body mass index (BMI) and offspring
birthweight, and some evidence of an association with
greater offspring BMI, weight or body fat mass in child-
hood. A small number of studies have also found links be-
tween paternal BMI and sperm or offspring neonatal blood
DNA methylation, but these have been based on candidate
genes and/or had very limited sample sizes.14–20
In the Pregnancy And Childhood Epigenetics (PACE)
consortium,21 we conducted meta-analyses of coordinated
epigenome-wide association studies (EWAS) exploring pre-
natal paternal BMI in relation to genome-wide DNA meth-
ylation at birth (cord blood; 13 independent data sets
across 10 cohorts) and in childhood (peripheral blood; 6
data sets across 9 cohorts). A major challenge in studies of
paternal effects is the correlation between paternal and ma-
ternal phenotypes and exposures, which could be due to
shared environments and/or assortative mating.22 Several
studies (e.g. 23–25) including a large PACE-consortium
study,26 have shown that maternal BMI is associated with
a variation in offspring DNA methylation. To help
Key Messages
• Previous small, mostly candidate gene studies have shown associations between paternal pre-pregnancy body mass
index (BMI) and offspring-blood DNA methylation.
• However, in our large meta-analysis of coordinated epigenome-wide association study results from a total of 19 data
sets across two time points, we found little evidence to support these findings, even at imprinted regions.
• This does not rule out the possibility of a paternal epigenetic effect in different tissues, at regions not covered by the
450k array, via different mechanisms or in populations with greater extremes of paternal BMI.
• More research is warranted to help in understanding the size and nature of contributions of paternal adiposity to
offspring epigenetics and health outcomes.
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disentangle any paternal effect from a maternal effect, we
adjusted paternal associations for maternal BMI. We also
conducted additional analyses with maternal BMI as the
main exposure (unadjusted and adjusted for paternal BMI)
and compared results to our primary analyses in which pa-
ternal BMI was the main exposure. Finally, we systemati-
cally reviewed the literature on associations between
paternal BMI and offspring or sperm DNA methylation in
humans and assessed whether our results were enriched for





The EWAS meta-analysis at birth included data from 13
independent data sets from 10 cohorts in PACE
(n¼ 4894): the Avon Longitudinal Study of Parents and
Children (ALSPAC)27–29; two independent data sets from
Born in Bradford (BiB)30; the Center for the Health
Assessment of Mothers and Children of Salinas
(CHAMACOS)31; the Generation R Study (GENR)32,33;
the Genetics of Overweight Young Adults34 (GOYA;
nested within the Danish National Birth Cohort); INfancia
y Medio Ambiente (INMA)35; three independent data sets
from the Norwegian Mother and Child Cohort Study
(MoBa1, MoBa2, MoBa3)36,37; Project Viva (Viva)38; and
two independent data sets generated as part of the
EXPOsOMICS39 project Piccolipiù40 and RHEA.41
The EWAS meta-analysis at childhood included data
from six data sets from nine PACE cohorts (n¼ 1982):
ALSPAC, CHAMACOS, Generation R, INMA, Project
Viva and the Human Early Life Exposome study
(HELIX).42 HELIX is a sample containing childhood
methylation data pooled from several other cohorts (BIB,
EDEN,43 INMA, MoBa and RHEA). We conducted a sen-
sitivity analysis excluding HELIX, because of concerns
about potential sample overlap (albeit at a different time
point) with the INMA sample.
Cohorts are summarized in Table 1 and more detailed
methods for each cohort are provided in Supplementary
Information File 1, available as Supplementary data at IJE
online.
Measurement of paternal and maternal BMIs
Paternal and maternal BMIs were calculated using either
self-reported or measured height and weight of participants
(Table 1). For paternal BMI, cohorts selected a time point
as close to the time of pregnancy as possible. Where possi-
ble, inclusion was restricted to biological fathers, but
paternity status was not ascertainable in all cohorts. For
maternal BMI, cohorts used self-reported pre-pregnancy
BMI or BMI measured in the early stages of pregnancy.
BMI was calculated in kg/m2 and then standardized for
each cohort by converting to internal Z-scores.
Measurement of DNA methylation
Biological samples were either cord-blood samples from
neonates or peripheral-blood samples from children. DNA
methylation was measured using either the llumina
InfiniumV
R
HumanMethylation450 (486 425 probes) or
EPIC (866 553 probes) BeadChip assay (Table 1). Probes
that were common to both arrays (maximum 453 008)
were included in the meta-analysis. Each cohort conducted
its own laboratory methods, quality control and normali-
zation, as detailed in Supplementary Information File 1,
available as Supplementary data at IJE online. All cohorts
used normalized, untransformed methylation beta values
on a scale of 0 to 1.
Other covariates
Questionnaire data were used to derive the following cova-
riates, which were included in all adjusted models regard-
less of whether the main exposure was paternal or
maternal BMI: maternal and paternal age (years); maternal
smoking status during pregnancy (preferred definition:
smoking throughout pregnancy/no smoking in pregnancy
or quitting in the first trimester, but some cohorts used
any/no smoking in pregnancy); paternal smoking status
during or prior to pregnancy (any smoking in this time/no
smoking in this time); maternal parity (one or more previ-
ous pregnancies/no previous pregnancies); and paternal
socio-economic position (higher/lower). For the latter vari-
able, precise definitions were cohort-specific but most
cohorts used paternal educational attainment (if data on
paternal socio-economic position were not available, ma-
ternal socio-economic position was used). In addition,
some secondary models were stratified by the sex of the
child. Cohort-specific information on covariate definitions
is provided in Supplementary Information File 1, available
as Supplementary data at IJE online. Some previous studies
of parental BMI and offspring outcomes have elected to
adjust for additional covariates such as gestational age at
delivery or birthweight. We chose not to adjust for these
factors because they cannot be true confounders of the as-
sociation of interest (they do not influence pre-pregnancy
parental BMI). They could, however, be mediators on the
causal pathway and therefore adjustment for these would
be over-adjustment of the potential effects of parental BMI
and could also introduce collider bias.44
Systematic differences between samples (e.g. those influ-
enced by technical batch) were addressed by generating 20
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surrogate variables (SVs) using the SVA45,46 R package.
The number of SVs (i.e. 20) was estimated using the
ALSPAC data set and then each cohort estimated 20 SVs
using their own data. Cellular heterogeneity was addressed
by estimating cell-type proportions using the Houseman al-
gorithm47 and either a cord-blood reference panel48 or a
peripheral-blood reference panel,49 depending on the
methylation time point.
Cohort-specific EWAS
Each cohort performed an independent EWAS according
to a common, pre-specified analysis plan and R script
(available on our Open Science Framework site at doi:
10.17605/OSF.IO/EBTW7). If cohorts had data for both
time points, EWAS were performed separately for birth
and childhood. Potential methylation outliers, thought to
be introduced by a technical error or a rare single-
nucleotide polymorphism (SNP), were identified and re-
moved using the Tukey method as previously described.50
Linear-regression models, modelling offspring methyla-
tion as the outcome and parental BMI as the exposure,
were applied to each CpG using the Limma R package.51
Two main models were run for both paternal and maternal
BMIs: (i) a basic model in which paternal or maternal BMI
associations were adjusted for estimated cell proportions,
SVs for technical batch, maternal and paternal age, mater-
nal smoking status during pregnancy, paternal smoking
status during or prior to pregnancy, paternal socio-
economic position and maternal parity; and (ii) a model
with additional adjustment for the other parent’s BMI. In
secondary analyses, the mutually adjusted models (i.e.
model (ii)) were run stratified by the sex of the offspring.
This is because there is some literature to support paternal
effects occurring in a sex-specific manner.52,53 All probes
were annotated to the human reference genome version 19,
build 37.
Other cohort-specific analyses
To allow us to explore the extent to which paternal BMI is
associated with offspring-blood-cell proportions (which is
an important source of variation in methylation data, but
also an interesting phenotype to study in its own right54),
cohorts provided results (effect estimate, standard error,
P-value) for linear regressions of each estimated cell type
on paternal BMI. These were then meta-analysed using the
R package metafor.55
Cohorts also provided the Spearman coefficient and P-
value for the correlation between maternal and paternal
BMIs to allow us to assess the likelihood of assortative
mating as an explanation for our results.
Meta-analysis
Fixed-effects meta-analysis weighted by the inverse of the
variance was performed at the University of Bristol using
METAL.56 A shadow meta-analysis was also conducted in-
dependently by an author at the University of Hasselt
(Rossella Alfano). All codes used to perform these analyses
are provided on our Open Science Framework site at doi:
10.17605/OSF.IO/EBTW7.
The EWAS meta-analysis pipeline was as follows:
1. Filter probes from cohort results files to remove
probes that are not common to both the EPIC and
450k array, control and QC probes, probes on SNPs,
cross-hybridizing probes according to Chen et al.57
and probes on the sex chromosomes.
2. Perform quality checks of cohort results by plotting
correlation matrices of effect estimates generated by
different models, generating QQ plots and calculating
Lambda values, plotting the distribution of effect esti-
mates and producing ‘precision plots’ of 1/median
standard error against the square root of the sample
size for each cohort and model.
3. Conduct a fixed-effects meta-analysis using METAL
for each model.
4. Adjust meta-analysis P-values for multiple testing us-
ing the false-discovery-rate (FDR) method. The
threshold used to define statistical evidence of an asso-
ciation was an FDR-adjusted P-value <0.05.
5. Perform checks of meta-analysed results by plotting a
correlation matrix of effect estimates generated by dif-
ferent models, generating QQ plots and calculating
Lambda values.
6. Conduct a leave-one-out analysis using the R package
metafor55 at sites with the smallest P-values. The
leave-one-out survival criteria we specified are: when
any single cohort is omitted, the meta-analysis effect
estimate should be in the same direction, not attenuate
substantially (arbitrarily defined as >20% change-in-
estimate) and not have a confidence interval that
crosses the null.
7. Conduct a meta-regression to explore the impact of
average age at DNA-sample collection on the child-
hood EWAS meta-analysis results.
8. Conduct a sensitivity analysis at the birth time point,
excluding cohorts that collected information on pater-
nal BMI based on maternal report (GOYA, INMA,
MoBa, Piccolipiù, Project Viva, RHEA) because of
concern about measurement error.
9. Conduct a sensitivity analysis at the childhood time
point excluding HELIX because of concerns about
overlap between some individuals in this data set and
individuals in INMA.
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10. Perform a look-up of any CpGs identified as associ-
ated with paternal BMI in the EWAS Catalog (a re-
pository of previously reported EWAS associations;
http://www.ewascatalog.org).
Comparison of results for maternal and paternal
BMIs
To assess whether paternal and maternal BMIs are associ-
ated with offspring methylation to similar extents and with
similar distributions throughout the genome, we compared
effect estimates for the EWAS meta-analyses with and
without mutual adjustment for the other parent’s BMI. At
the top 10 CpGs associated with paternal BMI with the
smallest P-values, we calculated the Cochrane Q statistic
to explore statistical evidence for differences between the
maternal- and paternal-effect estimates.
To explore the extent to which maternal BMI might ex-
plain associations between paternal BMI and offspring
methylation, we conducted Kolmogorov–Smirnov tests to
assess the enrichment of our EWAS meta-analysis results
for CpGs previously found to be associated with maternal
BMI in the PACE consortium.26
Systematic literature review
To identify previous human studies of paternal adiposity
and offspring or sperm methylation, we performed a sys-
tematic search of PubMed using the R package RISmed.58
The latest search was run in February 2020. Search terms
(Supplementary Information File 2, available as
Supplementary data at IJE online) were formed using inter-
sections of terms related to paternity, methylation and adi-
posity. Duplicate PubMed IDs and ineligible article types
(non-journal articles and reviews) were excluded. Titles/
abstracts were manually screened to assess inclusion based
on whether the study investigated paternal adiposity and
germ-cell/offspring methylation, and whether it did so in
humans. Information on study design, exposure, outcome,
tissue, sample size, species and key relevant findings was
manually extracted from the full text of included articles.
Testing for enrichment of candidate loci identified
through the literature
To explore the enrichment of our EWAS meta-analysis
results for loci identified through our literature search, we
tested whether the distribution of EWAS meta-analysis P-
values at these regions deviates from a null (uniform) dis-
tribution using Kolmogorov–Smirnov tests and compared
the direction of the effect estimate to what has been
reported previously. To identify CpG probes falling within
a particular gene, we defined the location of the gene
according to the GeneCards database (https://www.gene
cards.org) and human genome version 19, build 37.
Availability of data and code
All code used to generate our results is available on our
Open Science Framework site at doi: 10.17605/OSF.IO/
EBTW7. We are not able to publicly share individual-level
data from participating cohorts due to issues with consent
and ethics, although all summary statistics generated by
meta-analysis are also available at doi: 10.17605/OSF.IO/
EBTW7.
Results
EWAS meta-analysis at birth
Cohort summaries
Thirteen independent data sets were included in the EWAS
meta-analyses at birth. Table 2 summarizes key character-
istics of these cohorts (more details in Supplementary
Information File 3, available as Supplementary data at IJE
online). Around 48% of the babies were female. In all
cohorts, paternal BMI had a higher mean and a lower stan-
dard deviation (SD) compared with maternal BMI. There
was moderate correlation between both parents’ BMIs
(r¼ 0.2), which might be explained by assortative mating
and/or a shared environment.
Quality checks
Quality checks of cohort-specific EWAS results are sum-
marized in Supplementary Information File 4, available as
Supplementary data at IJE online. Generally, no major
problems were identified, but there were a small number of
extreme effect estimates in some cohorts, mainly in the
sex-stratified models in which the sample sizes were lower.
Quality checks of the meta-analysis results (Supplementary
Information File 5, available as Supplementary data at IJE
online) showed that these outliers had little weighting in
the meta-analysis and therefore little impact on the EWAS
meta-analysis results. Therefore, these values were not ex-
cluded from the meta-analysis.
Associations between paternal BMI and offspring
methylation at birth
Table 3 summarizes the results of each EWAS meta-
analysis model (full results available on our Open Science
Framework site at doi: 10.17605/OSF.IO/EBTW7). After
FDR correction for multiple testing, we did not identify
any CpG sites for which there was evidence of an associa-
tion between paternal BMI and offspring DNA methyla-
tion at birth (FDR< 0.05). Effect estimates for the model
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with and without adjustment for maternal BMI were very
similar: they correlated highly (Spearman’s r¼ 0.97) and
the median percentage difference in effect estimates be-
tween the models was 0.23% (interquartile range: 0.1%,
0.6%), suggesting that maternal BMI was not a strong con-
founder. In a sensitivity analysis, excluding cohorts that
defined paternal BMI based on maternal report did not in-
crease the number of CpGs with FDR-corrected P< 0.05.
In a sex-stratified analysis adjusted for maternal BMI,
we found some evidence of an association between methyl-
ation and paternal BMI at seven CpGs in female offspring
only (Table 4). Three of these did not survive the leave-
one-out analysis [i.e. on the omission of one cohort, the ef-
fect estimates were in different directions, changed consid-
erably (>20%) and/or had confidence intervals that
crossed the null; results in Supplementary Information File
Table 2 A summary of the sex of the child and parental BMI for each cohort in the birth meta-analysis






















ALSPAC 531 (267, 264) 25.0 (3.0) 6% 22.6 (3.3) 4% 0.2 (7.610–7)
Born in Bradford
(British Asian)
70 (27*, 43) 26.6 (5.3) 17% 26.2 (5.8) 21% 0.2 (1.110–1)
Born in Bradford
(White British)
115 (59, 56) 27.5 (4.7) 24% 26.7 (6.1) 24% 0.4 (9.110–4)
CHAMACOS 158 (80, 78) 28.0 (4.2) 32% 26.5 (4.5) 19% 0.1 (1.110–1)
Generation R 947 (476, 471) 25.2 (3.2) 7% 23.2 (3.9) 6% 0.2 (8.810–8)
GOYA 390 (190, 200) 25.1 (3.1) 6% 23.4 (3.7) 6% 0.1 (7.110–3)
INMA 352 (173, 179) 25.8 (3.5) 13% 23.8 (4.5) 9% 0.2 (4.710–5)
MoBa1 982 (458, 524) 25.6 (3.1) 8% 24.0 (4.1) 9% 0.1 (6.210–5)
MoBa2 621 (275, 346) 25.7 (3.1) 8% 24.3 (4.6) 11% 0.2 (2.210–8)
MoBa3 212 (109, 103) 26.0 (3.1) 9% 24.0 (3.9) 9% 0.3 (2.010–4)
Piccolipiù 98 (45, 53) 24.9 (3.0) 3% 22.6 (3.9) 8% 0.3 (2.610–3)
Project Viva 324 (160, 164) 26.3 (3.6) 13% 24.3 (4.9) 12% 0.3 (1.210–6)
RHEA 94 (45, 49) 27.2 (4.0) 20% 25.1 (5.5) 16% 0.3 (1.110–2)
Total or meana 4894 (2337, 2530) 26.98 (3.2) 10% 23.7 (4.1) 9% 0.2
aIn the ‘Total’ row, the average BMI and correlation values were calculated by weighting the by the inverse variance for each cohort.* too few to be included in
the sex-stratified meta-analysis.
BMI, body mass index; SD, standard deviation; cohort abbreviations described in the main text.












All offspring 0 n.a. 4894 1.13
All offspring (additionally adjusted for maternal BMI) 0 n.a. 4894 1.16
Female offspring (additionally adjusted for maternal BMI) 7 4 (57%) 2337 1.10
Male offspring (additionally adjusted for maternal BMI) 0 n.a. 2530 1.10
Maternal BMI
All offspring 39 35 (90%) 4894 1.10
All offspring (additionally adjusted for paternal BMI) 30 28 (93%) 4894 1.11
Female offspring (additionally adjusted for paternal BMI) 9 4 (44%) 2337 1.05
Male offspring (additionally adjusted for paternal BMI) 1 1 (100%) 2530 1.09
aAll models adjusted for maternal and paternal age, maternal and paternal smoking, paternal education, maternal parity, estimated cell counts and 20 surrogate
variables.
bThe genomic inflation factor (k) estimates the extent of the bulk inflation of EWAS P-values and the excess false-positive rate. 1¼ no inflation; >1 some evi-
dence of inflation.
BMI, body mass index.
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6, available as Supplementary data at IJE online]. Of the
four remaining CpGs, according to the EWAS Catalog,
one (cg23487201 at APCDD1L) has previously been asso-
ciated with clear cell carcinoma and pancreatic ductal ade-
nocarcinoma and another (cg00039564 at TAX1BP1) has
previously been found to be associated with rheumatoid
arthritis.
Comparison of estimates for paternal and maternal BMIs
Maternal BMI was associated with methylation at many
more CpG sites than paternal BMI was (Table 3). In the
main models not stratified by sex, there were 39 CpGs as-
sociated with maternal BMI before adjustment for paternal
BMI and 30 after (FDR-adjusted P<0.05); 26 overlapped.
Most associations survived a leave-one-out sensitivity
analysis.
At the top CpGs associated with paternal BMI at a re-
laxed (but arbitrary) P-value threshold of P<110–5, the
estimated paternal effect was greater (further from the
null) than the estimated maternal effect, even after adjust-
ment for the other parent’s BMI (Figure 1). There was also
strong evidence of heterogeneity between the maternal and
paternal mutually adjusted estimates (all heterogeneity
FDR-adjusted P-values<0.05; I2 ranging from 86.6 to
96.4). However, apart from at the most robustly paternal
BMI-associated CpG sites, this pattern (of greater paternal-
Table 4 CpGs associated with paternal BMI with FDR-adjusted P<0.05 in female offspring only at birth (estimates are adjusted
for maternal BMI)















acg03395511 (DUSP22) 2.93 (2.55, 3.30) 710–53 98.7 (610–179) 0.39 (0.01, 0.77) 0.04 0.07 (–0.21, 0.35) 0.6
acg27586797 (intergenic) –4.90 (–5.80, –4.00) 210–26 75.8 (110–5) 1.33 (–0.03, 2.68) 0.05 –0.30 (–1.25, 0.65) 0.5
acg04481923 (MIR886) 2.07 (1.42, 2.72) 410–10 90.4 (310–19) –0.08 (–0.73, 0.57) 0.8 –0.02 (–0.46, 0.43) 0.9
cg09452082 (intergenic) –0.43 (–0.59, –0.26) 4 10–7 79.3 (210–7) –0.13 (–0.29, 0.04) 0.1 –0.18 (–0.29, –0.06) 0.003
cg23487201 (APCDD1L) –0.17 (–0.24, –0.11) 5 10–7 15.2 (0.3) 0.03 (–0.03, 0.09) 0.4 –0.06 (–0.10, –0.01) 0.01
cg19702703 (AFAP1) –0.45 (–0.63, –0.27) 6 10–7 1.3 (0.4) –0.13 (–0.30, 0.04) 0.1 –0.23 (–0.35, –0.11) 0.0001
cg00039564 (TAX1BP1) –0.19 (–0.26, –0.11) 810–7 23.4 (0.2) 0.03 (–0.04, 0.11) 0.4 –0.05 (–0.10, 0.00) 0.06
‘Estimate’ can be interpreted as the difference in the offspring percentage methylation per 1-standard-deviation increase in paternal BMI, after adjustment for
all covariates including maternal BMI.
aCpG did not survive leave-one-out analysis, indicating that the strong association was driven by a single cohort.
BMI, body mass index.
Figure 1 A comparison of paternal and maternal body mass index (BMI)-effect estimates at CpGs with P< 110–5 in the paternal BMI epigenome-
wide association study (EWAS) meta-analysis at birth. CpGs were selected if they were associated with paternal BMI with a P-value <1 10–5 in the
model that was not adjusted for maternal BMI. Points show EWAS meta-analysis effect estimates, bars show 95% confidence intervals. Confidence
intervals are not adjusted for multiple testing.
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than maternal-effect estimates) was not observed. In fact,
throughout the genome, around half (49.6%) of the CpGs
had larger absolute effect estimates for paternal BMI and
the other half (50.2%) had larger absolute effect estimates
for maternal BMI. Figure 2 shows that maternal-effect esti-
mates (before adjustment for paternal BMI) were similar in
size to paternal-effect estimates, and the distribution of ef-
fect estimates across the genome was similar regardless of
parent. Results were very similar after mutual adjustment
for the other parent’s BMI (Supplementary Information
File 7, available as Supplementary data at IJE online).
In a previous PACE-consortium study,26 we identified
86 cord-blood CpGs associated with maternal BMI in an
EWAS meta-analysis across 19 cohorts (9 of which also
contributed results to the current study). Of the 86 CpGs
identified in that previous study (which had higher statisti-
cal power to detect associations), 64 were available in the
current study after probe filtering. To explore the extent to
which maternal BMI might be driving any association be-
tween paternal BMI and offspring methylation in the cur-
rent study, we assessed the enrichment of our paternal
BMI EWAS meta-analysis results for these 64 maternal
BMI-associated CpGs. We found little evidence of enrich-
ment (Kolmogorov–Smirnov P-value for inflation of
EWAS P-values¼ 0.54 in EWASs unadjusted for maternal
BMI; 0.61 in EWASs adjusted for maternal BMI), suggest-
ing that any relationship between paternal BMI and off-
spring methylation was unlikely to be driven by
confounding by maternal BMI, even before adjustment for
maternal BMI. Conversely, the maternal BMI EWAS meta-
analysis results in the current study were highly enriched
for previously identified maternal BMI-associated CpGs
(Kolmogorov–Smirnov P for inflation¼ 2.2 10–16 in
EWASs adjusted and unadjusted for paternal BMI). This
finding was as expected, given that the main exposure was
the same and the samples were overlapping, but it high-
lights the ability of this analysis to detect strong associa-
tions with maternal BMI if they exist.
EWAS meta-analysis at childhood
Cohort summaries
Six cohorts were included in the EWAS meta-analyses at
childhood. Table 5 summarizes the key characteristics of
these cohorts. Around 48% of the children were female. In
all cohorts, paternal BMI had a higher mean and a lower
SD compared with maternal BMI.
Quality checks
Quality checks of cohort-specific EWAS results are sum-
marized in Supplementary Information File 8, available as
Supplementary data at IJE online. Meta-analysis quality
checks are summarized in Supplementary Information File
9, available as Supplementary data at IJE online. We did
not exclude any data following these checks.
Figure 2 A comparison of paternal and maternal body mass index (BMI) epigenome-wide association study (EWAS) effect estimates across the ge-
nome. Absolute effect estimates (y-axis) are plotted against genomic location (x-axis; numbers indicate chromosome number). Paternal BMI EWAS
meta-analysis results are plotted on the top, with maternal EWAS meta-analysis results on a mirrored axis below. Models were not mutually adjusted
for the other parent’s BMI (for a comparison of the mutually adjusted results, see Supporting Information File 7, available as Supplementary data at
IJE online).
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Associations between paternal BMI and offspring
methylation in childhood
Table 6 summarizes the results of each EWAS meta-
analysis model (full results available on our Open Science
Framework site at doi: 10.17605/OSF.IO/EBTW7). There
was one CpG for which we found evidence (FDR-adjusted
P< 0.05) of an association with paternal BMI [cg2720130
at GIP on chromosome 17; ß 0.4%, 95% confidence inter-
val (CI) 0.2% to 0.5%, P¼8.8 10–8] and one (different)
CpG with evidence of an association with maternal BMI
(cg07099084 in an intergenic region on chromosome 1, ß –
0.05%, 95% CI –0.03% to –0.06%, P¼ 1.110–7).
However, neither survived mutual adjustment for the other
parent’s BMI, neither was associated with parental BMI in
the birth analysis and one (cg07099084) did not survive a
leave-one-out analysis (Supplementary Information File
10, available as Supplementary data at IJE online).
Excluding HELIX from the full meta-analysis did not
change the number of associations with FDR-adjusted
P< 0.05. A meta-regression also showed little evidence
that the mean age of the children at methylation measure-
ment was associated with EWAS meta-analysis effect esti-
mates (Supplementary Information File 10, available as
Supplementary data at IJE online).
Analysis of cell proportions
Paternal BMI was not associated with the proportion of
any cell type in offspring blood (Supplementary
Information File 11, available as Supplementary data at
IJE online), except for a very small difference in the
Table 5 A summary of sex and age of the child and parental BMI for each cohort in the childhood meta-analysis
























ALSPAC 570 (280, 290) 7.5 (0.2) 25.0 (3.1) 7% 22.6 (3.4) 4% 0.2 (5.110–6)
CHAMACOS 108 (56, 52) 9.2 (0.3) 27.6 (3.4) 27% 27.0 (4.4) 22% 0.2 (2.910–2)
Generation R 335 (174, 161) 6.0 (0.4) 25.0 (3.3) 6% 24.1 (3.9) 6% 0.2 (1.510–5)
HELIX 516 (231, 285) 8.4 (1.7) 26.6 (3.7) 18% 23.9 (4.4) 9% 0.3 (1.110–10)
INMA 177 (87, 90) 4.4 (0.2) 26.0 (3.6) 15% 24.6 (5.1) 13% 0.3 (9.610–5)
Project Viva 276 (132, 144) 7.8 (0.7) 26.4 (3.7) 15% 24.5 (4.7) 13% 0.4 (4.210–13)
Totala 1982 (960, 1022) 6.9 (0.3) 25.7 (3.4) 12% 24.3 (5.2) 9% 0.3
aIn the ‘Total’ row, the average BMI, age and correlation values were calculated by weighting by the inverse variance for each cohort.
BMI, body mass index.













All offspring 1 1 (100%) 1982 1.03
All offspring (additionally adjusted for maternal BMI) 0 n.a. 1982 1.00
Female offspring (additionally adjusted for maternal BMI) 0 n.a. 960 1.00
Male offspring (additionally adjusted for maternal BMI) 0 n.a. 1022 1.05
Maternal BMI
All offspring 1 0 (0%) 1982 1.11
All offspring (additionally adjusted for paternal BMI) 0 n.a. 1982 1.08
Female offspring (additionally adjusted for paternal BMI) 0 n.a. 960 1.06
Male offspring (additionally adjusted for paternal BMI) 0 n.a. 1022 1.07
aAll models adjusted for maternal and paternal age, maternal and paternal smoking, paternal SEP, maternal parity, estimated cell counts and 20 surrogate
variables.
bThe genomic inflation factor (k) estimates the extent of the bulk inflation of EWAS P-values and the excess false-positive rate. 1¼ no inflation; >1 some evi-
dence of inflation.
BMI, body mass index.
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estimated proportion of nucleated red blood cells in off-
spring cord blood (nRBCs; 0.001 greater proportion of
nRBCs per 1-SD increase in paternal BMI; 95% CI
0.0004 to 0.0017; P¼ 0.001) and an even smaller differ-
ence in the proportion of CD4 T-cells in childhood pe-
ripheral blood (0.0007 lower proportion of CD4 T-cells
per 1-SD increase in paternal BMI; 95% CI –0.0013 to –
0.0002; P¼ 0.007), which appeared to be largely driven
by the HELIX data set and did not survive a sensitivity
analysis excluding HELIX.
Systematic literature review
Figure 3 summarizes the workflow and Table 7 outlines
the seven included studies resulting from a systematic liter-
ature review of human studies of paternal adiposity and
offspring or gamete methylation. There were five studies of
imprinted regions and two untargeted array-based studies.
Four studies investigated DNA methylation in offspring
cord blood, two in paternal sperm and one in both.
Comparison to the literature
Imprinted regions identified in studies by Soubry et al.
and Potabattula et al
At paternally imprinted regions identified in the literature
review, EWAS meta-analysis effect estimates for the associ-
ation between paternal BMI and cord-blood methylation
(adjusted for maternal BMI) were small with no clear trend
in direction (Figure 4). Findings were similar for the EWAS
model unadjusted for maternal BMI (Supplementary
Information File 12, available as Supplementary data at
IJE online).
Regions identified by Donkin et al
Donkin et al.18 reported 9081 genes differentially methyl-
ated between sperm samples from lean and obese men
(with FDR-adjusted P< 0.1). Of these, we could only map
to 511 CpGs at the same genomic positions in our cord-
blood EWAS meta-analysis results, because Donkin et al.
measured methylation using reduced representation bisul-
phite sequencing (RRBS) with a higher coverage of the ge-
nome than the 450k array. In our paternal BMI EWAS
meta-analysis at birth (adjusted for maternal BMI), we
found the same direction of effect at only roughly half of
these genes (252/511) and only 17 of these had a P-val-
ue< 0.05, with none surviving FDR correction for multiple
testing at either 511 or 252 sites. QQ plots and a
Kolmogorov–Smirnov test suggested that our EWAS P-val-
ues at these 252 sites were not smaller than would be
expected by chance (Supplementary Information File 12,
available as Supplementary data at IJE online;
Kolmogorov–Smirnov P¼ 0.27). Findings were similar
when using the EWAS meta-analysis P-values from the pa-
ternal BMI model that was not adjusted for maternal BMI
(Supplementary Information File 12, available as
Supplementary data at IJE online).
CpGs identified by Noor et al
In Project Viva (a cohort that also contributed results to
our meta-analysis), Noor et al. identified nine CpGs for
which cord-blood methylation was associated with peri-
conceptional paternal BMI after adjustment for maternal
BMI.20 In our results at birth, we found the same direction
of estimated effect at seven out of nine CpGs. Only one of
these had a P-value< 0.05 but this association also sur-
vived FDR correction for multiple testing at nine sites
(cg04763273 mapping to TFAP2C; –0.41% difference in
methylation per 1-SD increase in paternal BMI; 95% CI –
0.67 to –0.15; P¼0.002). According to our leave-one-out-
analysis criteria, this CpG ‘survived’ after omission of
Project Viva, but it did not survive after omission of
Generation R. A Kolmogorov–Smirnov test suggested that
our EWAS P-values at the nine CpGs identified by Noor et
al. were not smaller than would be expected by chance
(Kolmogorov–Smirnov P¼ 0.21). Noor et al. also identi-
fied 18 CpGs for which cord-blood methylation was asso-
ciated with paternal BMI when the analysis was restricted
to a subset of offspring of mothers with a BMI> 25. In our
(unstratified) results at birth, we found the same direction
of estimated effect at only 9 of these 18 CpGs, only 1 had a
P-value< 0.05 (cg04763273) and a Kolmogorov–Smirnov
test suggested that our EWAS P-values were not smaller
than would be expected by chance (Kolmogorov–Smirnov
P¼ 0.54).
Figure 3 The systematic-review process used to identify human studies
of paternal adiposity and offspring or germ-cell methylation
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Discussion
Summary and interpretation of findings
In coordinated EWAS meta-analysis using a total of 19
data sets, at a genome-wide level of significance (FDR-ad-
justed P<0.05), we found little evidence of an association
between prenatal paternal BMI and offspring-blood DNA
methylation at birth or in childhood. In secondary sex-
stratified analyses, we found robust associations between
paternal BMI and cord-blood methylation at just four
CpGs in female offspring only. There was little evidence of
residual confounding by maternal BMI, and paternal BMI
was not strongly associated with estimated cell
heterogeneity at either time point. At the top CpGs most
strongly associated with paternal BMI, estimates of the ef-
fect of paternal BMI on methylation were larger than esti-
mates of the effect of maternal BMI, suggesting some
evidence of paternal-specific association at these top CpGs
(although not passing our P-value threshold). However,
more associations with maternal BMI than paternal BMI
surpassed our P-value threshold (FDR-adjusted P< 0.05)
and, across the whole genome, estimates of the effect of pa-
ternal BMI were similar in magnitude to those of maternal
BMI.
The lack of statistical support for paternal associations
may reflect limited power and we cannot discount an
Figure 4 Paternal body mass index (BMI)-effect estimates at CpGs within imprinted regions. Each panel shows a different imprinted gene, with CpGs
arranged in order on the x-axis. The blue ribbon shows the 95% confidence intervals. All results are adjusted for maternal BMI.
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impact of paternal BMI on offspring DNA methylation
without studies in populations with greater variability in
paternal BMI and/or larger sample sizes. Although we note
that we found associations with maternal BMI using ex-
actly the same samples, if any true effect of paternal BMI is
weaker than the maternal effect, power could still be an is-
sue. Furthermore, we cannot rule out an impact on DNA
methylation measured in different tissues and/or at regions
not covered by the 450k array.
Comparison to the literature
Our largely null findings are in contrast to some previous
findings. In a systematic review, we identified seven studies
that have previously reported associations between pater-
nal BMI and sperm or offspring methylation in humans.
Five of these (three from one study and group14–16 and two
from another17,19) were candidate gene studies that found
associations between paternal obesity or higher BMI and
sperm or offspring-cord-blood methylation at imprinted
regions (all after adjustment for maternal BMI or obesity).
There is a strong biological rationale for studying
imprinted regions in the context of paternal exposures, be-
cause methylation marks at imprinted regions appear to
survive the wave of demethylation that occurs following
fertilization and therefore have the potential to pass on epi-
genetic information from the gametes to the offspring.10,59
However, where studies of imprinted genes have consid-
ered the same loci, the directions of the estimated effects
have been discordant between studies. For example,
Potabattula et al.17 found a positive correlation between
paternal BMI and cord-blood methylation at MEST but
Soubry et al.14 found that the cord blood of the offspring
of obese fathers was lower than that of controls, indicating
an inverse correlation with BMI. There are also paradoxi-
cal findings at SGCE/PEG10 and IGF2 between studies of
sperm16 and cord blood14 but, if methylation differences in
sperm are transmitted to offspring, we would expect the
same direction of estimated effects in these tissues. In our
EWAS meta-analysis of paternal BMI, we found little evi-
dence of enrichment for imprinted genes. Effect estimates
at individual CpGs within imprinted regions were small
and the direction of effect varied within most genes
(Figure 4). Therefore, we found little evidence to support
the findings of these candidate gene studies, despite having
a much larger sample size and statistical power. However,
it should be noted that the Illumina BeadChip array does
not provide full coverage of imprinted regions, so further,
more detailed analysis of these regions may be justified.
One small study (total n¼ 23; 10 obese) by Donkin et al.18
used an untargeted genome-wide approach that identified
>9000 CpGs throughout the genome differentially methyl-
ated in the sperm of obese vs lean men. Only 511 of these
CpGs were available in our meta-analysis but we found little
evidence of an association at these. The difference in findings
of the two studies could reflect a number of factors, including
differences in the studied tissue (sperm vs offspring blood),
technology (RRBS vs 450k), definition of the phenotype (i.e.
obese/lean vs BMI over the whole range) or study sample (e.g.
all the obese men in Donkin et al. were glucose-intolerant).
Finally, in our meta-analysis, we replicated the direction
of effect at seven out of nine CpGs identified in Noor et
al.’s study of periconceptional paternal BMI and cord-
blood DNA methylation in Project Viva.20 One of these
CpGs (cg04763273 near TFAP2C) appeared to be robustly
associated with paternal BMI, but we found limited evi-
dence to support their other findings. Our study designs
were similar in that we used the same Illumina array, expo-
sure definition, offspring tissue and time point, and even
had some sample overlap (Project Viva contributed results
to our meta-analysis). However, there were some differen-
ces in the model and our sample size was >11 times larger
and therefore more robust for identifying false positives.
Strengths
Analyses were conducted according to a pre-specified, har-
monized analysis plan, which is publicly available to aid
reproducibility. All the code used to conduct these analyses
and all the resulting EWAS meta-analysis summary statis-
tics are publicly available on our Open Science Framework
site at doi: 10.17605/OSF.IO/EBTW7. This means that
new studies with relevant data could undertake identical
analyses and meta-analyse with our results to produce
more precise estimates.
Our study uses a sample size of 4894, which is >11-fold
larger than all the independent studies identified in our sys-
tematic review (Table 7), the largest of which has a sample
size of 429. It draws together rich data from multiple birth
cohorts internationally and this richness allowed us to adjust
for important potential confounders. We also attempted to
adjust for systematic variation in the DNA-methylation data
by generating and adjusting for SVs, which is an approach
that has been shown to reduce the risk of false positives.45 In
a further attempt to ensure the robustness of our results, we
conducted sensitivity analyses (leave-one-out at top sites, ex-
cluding cohorts with only maternal-reported paternal BMI,
excluding HELIX from the genome-wide meta-analysis, and
meta-regression of age).
Our rich data enabled us to conduct a series of novel
analyses. First, we explored associations between paternal
prenatal BMI and offspring DNA methylation at child-
hood, which allows exploration of the persistence of asso-
ciations from birth and/or the effect of paternal BMI
postnatally (which we would expect to be correlated with
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prenatal paternal BMI). Second, we explored associations
between paternal BMI and cellular heterogeneity, which is
an important source of variation in methylation data, but
also an interesting phenotype to study in its own right.54
Third, we have previously shown that maternal BMI is as-
sociated with offspring methylation, which may reflect a
causal intrauterine effect at some CpGs.26 Therefore, to
help us tease apart paternal from maternal effects, we com-
pared paternal models adjusted and unadjusted for mater-
nal BMI and we also studied maternal BMI as the main
exposure. A particular advantage here was that we in-
cluded the same samples in both analyses and adjusted for
the same covariates, so the sample sizes were the same and
the main exposure (paternal or maternal BMI) was the
only difference between models. We calculated the correla-
tion between maternal and paternal BMI in each cohort,
which provided modest support for assortative mating,
but, by comparing paternal- and maternal-effect estimates
and assessing the enrichment of our paternal results for the
CpGs that we previously identified as associated with ma-
ternal BMI,26 we were able to infer that maternal BMI was
not an important confounder driving associations between
paternal BMI and offspring methylation.
Limitations
There are a number of limitations that should be consid-
ered when interpreting our results. First, the 450k array
covers only 1.7% of CpGs on the genome, so regions (in-
cluding imprinted regions) that might be differentially
methylated in association with paternal BMI might be
missed. Second, BMI could be a poor measure of paternal
adiposity in our sample, partly due to general issues with
the use of BMI as a measure of adiposity60,61 (perhaps par-
ticularly in men) and partly due to measurement error in-
troduced by self- or partner report. One study showed that
lean mass explained more variability in men’s BMI than
body fat did, whereas the opposite was seen in women.60
Measurement error might be higher for paternal BMI than
maternal BMI because few cohorts had direct measure-
ments and, in some instances, BMI was reported for the fa-
ther by the mother, introducing additional measurement
error to the questionnaire-reported variable (however, we
found similar results in our EWAS meta-analysis when we
excluded cohorts that used maternal report to define pater-
nal BMI). More variation in offspring methylation might
be captured by another measure such as fat-mass percent-
age or a measure of ‘lipotoxicity’61 but these data were not
available. Third, offspring blood might not be the most
suitable tissue to study and effects might be seen in other
tissues such as adipose (given previous evidence of associa-
tions between paternal and offspring adiposity) but, again,
we were limited by data availability. Fourth, the range of
paternal BMI in our study sample could be insufficient to
show an effect. As with associations between maternal
BMI and offspring adiposity,62 there might be a J- or U-
shaped relationship between paternal BMI and offspring
outcomes, whereby strong associations are only seen at the
extremes of the distribution. We anticipated that we would
not have enough power to dichotomize into (extreme)
obese and lean groups, so we were limited to only studying
paternal BMI across the whole range as a continuous vari-
able. Indeed, in our birth analysis, only 10% of fathers
across all cohorts were obese (Table 2; Supplementary
Information File 3, available as Supplementary data at IJE
online), which is the same as a recent estimate of the
worldwide prevalence of obesity in men, but much lower
than the estimated prevalence of obesity in adults living in
Europe (23%) and America (28%),63 where most of our
sample reside. This relatively low occurrence of paternal
obesity (and therefore variability in BMI) in our sample
may partly explain why we did not find stronger evidence
of an association with our outcome. Finally, paternal data,
including paternal BMI, from birth-cohort studies are po-
tentially more at risk of bias than maternal data. Lower
prioritization and greater difficulties in recruiting fathers
can introduce a higher degree of missing data for fathers
compared with that for mothers. If paternal participation
is related to BMI, this could create a selection bias in our
sample. Additionally, non-paternity (i.e. partners not being
genetically related to their offspring) might also introduce
bias if it is related to paternal BMI. Both of these issues
could bias paternal estimates towards the null and there-
fore could be a plausible non-biological reason for our ob-
servation of more FDR< 0.05 associations between
offspring methylation and maternal than paternal BMI.
Suggestions for further research
Fathers are a potential long-overlooked target for public-
health advice and interventions to improve child health, as
well as the health of the fathers themselves and their part-
ners.3 Paternal effects on offspring health have been ob-
served, so there is a logical motivation to further
investigate the potential underlying molecular mechanisms.
As mentioned above, in studies of the effect of paternal ad-
iposity, this work could focus on extreme ends of the BMI
distribution and/or other more informative measures of ad-
iposity such as fat-mass index, waist circumference or
measures of lipotoxicity.61 Evidence from animal studies
suggests that other epigenetic mechanisms such as long
non-coding RNAs or tRNAs could be more likely intergen-
erational carriers of paternal information than DNA
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methylation and it would be useful to extend these investi-
gations to humans.
There is also huge scope to study the effects of other pa-
ternal characteristics, some of which might be related to
BMI, such as chronic inflammation, circulating levels or di-
etary intake of nutrients and nutritional supplements (espe-
cially those that influence one carbon metabolism, such as
folate) and health behaviours like smoking and alcohol
consumption. Studies of paternal effects are increasingly
appearing in the literature (although still lagging far behind
studies of maternal effects).3,64 Indeed, studies of paternal
effects on a wide range of phenotypes are underway in
many of the PACE-consortium cohorts that contributed to
this paper [e.g. see the Exploring Prenatal Influences on
Childhood Health study, which is a multicohort study of
effects of maternal and paternal prenatal health behaviours
on childhood health over multiple domains].
Conclusion
In this large EWAS meta-analysis, we found little evidence
of an association between paternal pre-pregnancy BMI and
offspring DNA methylation in blood, including at
imprinted genes. However, this does not rule out the possi-
bility of a paternal epigenetic effect in different tissues or
via different mechanisms. More research is warranted to
gain a greater understanding of the size and nature of con-
tributions of paternal adiposity to offspring outcomes
more broadly.
Supplementary data
Supplementary data are available at IJE online.
Full list of authors:
Gemma C Sharp,1* Rossella Alfano,2,3 Akram
Ghantous,4 Jose Urquiza,5,6 Sheryl L Rifas-Shiman,7
Christian M Page,8,9 Jianping Jin,10 Silvia Fernández-
Barrés,5,6,11 Gillian Santorelli,12 Gwen Tindula,13 Paul
Yousefi,1 Leanne Kupers,1 Carlos Ruiz-Arenas,5,6,11
Vincent WV Jaddoe,14,15 Dawn DeMeo,16,17 Serena
Fossati,5,6,11 John Wright,12 Karen Huen,18 Maja
Popovic,19 Ellen A Nohr,20,21 George Davey Smith,1
Johanna Lepeule,22 Andrea Baccarelli,23 Maria C
Magnus,8 Wenche Nystad,24 Maribel Casas,5,6,11 Emily
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